[1] Medina J,Jones EA, Garcia Monzon C, et al. Immunopathogenesis of cholestatic autoimmune liver diseases. Eur J Clin Invest, 2001, 31: 64-71.
[2] Heathcote EJ. Evidence-based therapy of primary biliary cirrhosis. Eur J Gastroenterol Hepatol, 1999, 11: 607-615.
[3] Kim KA, Jeong SH. The diagnosis and treatment of primary biliary cirrhosis. Korean J Hepatol,2011,17: 173-179.
[4] Muratori P, Muratori L, Gershw in ME, et al.True antimitochondrial antibody- negative primary biliary cirrhosis, low sensitivity of the routine assays, or both. Clin Exp Immunol, 2004, 135: 154-158.
[5] Nishio A, Van de Water J, Leung PS, et al. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology, 1997, 25: 1085 - 1089.
[6] 潘敏鸿, 周晓军. 自身免疫性肝病的病理诊断.中华病理学杂志, 2007, 36: 772.
[7] Moreira RK,Revetta F,Koehler E,et al.Diagnostic utility of IgG and IgM immunohisto-chemistry in autoimmune liver disease.World J Gastroenterol,2010,16:453-457. |
